<DOC>
	<DOCNO>NCT01858129</DOCNO>
	<brief_summary>Transient Tachypnea Newborn ( TTN ) common respiratory disorder affect late preterm term baby cause lung edema result delay absorption fetal alveolar lung fluid . The investigator hypothesize ENAC expression up-regulated result administration corticosteroid . This effect lead enhance absorption fetal lung fluid finally treat TTN . The aim study evaluate whether inhaled corticosteroid reduce respiratory distress morbidity late preterm term neonate present TTN .</brief_summary>
	<brief_title>Inhaled Corticosteroids Treatment Transient Tachypnea Newborn</brief_title>
	<detailed_description>The primary outcome measure assessment respiratory distress reflect TTN clinical score neonate present TTN treat inhaled corticosteroid compare placebo .</detailed_description>
	<mesh_term>Transient Tachypnea Newborn</mesh_term>
	<mesh_term>Tachypnea</mesh_term>
	<criteria>Late preterm term infant ( postmenstrual age â‰¥ 34 week ) deliver cesarean section vaginal delivery Diagnosis TTN Parents sign informed consent Meconium aspiration syndrome Respiratory distress syndrome Congenital heart disease Non respiratory disorder cause tachypnea</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>6 Hours</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>TTN</keyword>
</DOC>